These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 621570)

  • 1. Biodistribution of intravenously injected [14C] doxorubicin and [14C] daunorubicin in mice: concise communication.
    Harrison K; Wagner NH
    J Nucl Med; 1978 Jan; 19(1):84-6. PubMed ID: 621570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of daunomycin and adriamycin in mice. A comparative study.
    Rosso R; Esposito M; Sala R; Santi L
    Biomedicine; 1973 Jul; 19(7):304-7. PubMed ID: 4593553
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of daunomycin-antibody immunoconjugates in managing soft tissue sarcomas: nude mouse xenograft model.
    Stastny JJ; Das Gupta TK
    Cancer Res; 1993 Dec; 53(23):5740-4. PubMed ID: 8242630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
    Deprez-de Campeneere D; Baurain R; Trouet A
    Cancer Treat Rep; 1979 May; 63(5):861-7. PubMed ID: 455327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Daunomycin and adriamycin antitumor cell antibody conjugates.
    Hurwitz E; Levy R; Maron R
    Isr J Med Sci; 1975 Dec; 11(12):1396. PubMed ID: 1218993
    [No Abstract]   [Full Text] [Related]  

  • 6. Compartmentalization of adriamycin and daunomycin in cultured chick cardiac myocytes. Effects on synthesis of contractile and cytoplasmic proteins.
    Lewis W; Galizi M; Puszkin S
    Circ Res; 1983 Sep; 53(3):352-62. PubMed ID: 6883654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.
    Pacciarini MA; Barbieri B; Colombo T; Broggini M; Garattini S; Donelli MG
    Cancer Treat Rep; 1978 May; 62(5):791-800. PubMed ID: 657163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative mammalian metabolism of adriamycin and daunorubicin.
    Loveless H; Arena E; Felsted RL; Bachur NR
    Cancer Res; 1978 Mar; 38(3):593-8. PubMed ID: 626965
    [No Abstract]   [Full Text] [Related]  

  • 10. Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.
    Chervinsky DS; Wang JJ
    J Med; 1976; 7(1):63-79. PubMed ID: 1064679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin and daunorubicin disposition in the rabbit.
    Bachur NR; Hildebrand RC; Jaenke RS
    J Pharmacol Exp Ther; 1974 Nov; 191(2):331-40. PubMed ID: 4417723
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative uptake of adriamycin and daunorubicin in sensitive and resistant friend leukemia cells measured by flow cytometry.
    Tapiero H; Fourcade A; Vaigot P; Farhi JJ
    Cytometry; 1982 Mar; 2(5):298-302. PubMed ID: 6951693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the pharmacokinetics of daunomycin in normal and leukemic rats.
    Nooter K; Sonneveld P; Martens A
    Cancer Res; 1985 Sep; 45(9):4020-5. PubMed ID: 4027999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
    Schwartz HS; Grindey GB
    Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
    [No Abstract]   [Full Text] [Related]  

  • 15. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the cardiotoxicity of the anthracycline antibiotics, carminomycin and adriamycin, in white mice].
    Gol'dberg LE; Shepelevtseva NG; Belova IP; Vertogradova TP
    Antibiotiki; 1976 Dec; 21(12):1106-13. PubMed ID: 1020945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
    Hofland KF; Thougaard AV; Sehested M; Jensen PB
    Clin Cancer Res; 2005 May; 11(10):3915-24. PubMed ID: 15897593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.
    Koutinos G; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
    Anticancer Res; 2002; 22(2A):815-20. PubMed ID: 12014656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of new derivatives of daunorubicin and adriamycin with DNA.
    Arlandini E; Vigevani A; Arcamone F
    Farmaco Sci; 1977 May; 32(5):315-23. PubMed ID: 862886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA breaks in P288 tumor cells in mice after treatment with daunorubicin and adriamycin.
    Schwartz HS
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):51-64. PubMed ID: 1124321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.